Imbalance in the expression of the activating type I and the inhibitory type II interleukin 1 receptors in endometriosis

Human Reproduction

Volumn 22, Issue 5, 2007, Pages 1464-1473

  Akoum, Ali ^a,b   Lawson, C ^a,b   Herrmann Lavoie, C ^a,b   Maheux, R ^a,b  

^a Université Laval   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Endometriosis; Endometrium; IL1R1; IL1R2; Lesion

Indexed keywords

COMPLEMENTARY DNA; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; VASCULOTROPIN; IL1R1 PROTEIN, HUMAN; IL1R2 PROTEIN, HUMAN; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 1 RECEPTOR TYPE II; INTERLEUKIN 1BETA; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ADULT; ARTICLE; CELL ACTIVATION; CELL ACTIVITY; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; ENDOMETRIOSIS; ENDOMETRIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; BIOSYNTHESIS; ENDOMETRIUM; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; METABOLISM; UPREGULATION;

ADULT; BLOTTING, WESTERN; CHEMOKINE CCL2; DOWN-REGULATION; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INTERLEUKIN-1BETA; RECEPTORS, INTERLEUKIN-1 TYPE I; RECEPTORS, INTERLEUKIN-1 TYPE II; TRANSFECTION; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34447094490     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dem021     Document Type: Article

References (47)

1. Akoum A, Lemay A, Brunet C and Hebert J (1995a) Cytokine-induced secretion of monocyte chemotactic protien-1 by human endometriotic cells in culture. The Groupe d'Investigation en Gynecologie. Am J Obstet Gynecol 172,594-600.
2. Akoum A, Lemay A, Brunet C and Hebert J (1995b) Secretion of monocyte chemotactic protein-1 by cytokine-stimulated endometrial cells of women with endometriosis. Le groupe d'investigation en gynecologie. Fertil Steril 63,322-328.
3. Akoum A, Lemay A, McColl S, Turcot-Lemay L and Maheux R (1996a) Elevated concentration and biologic activity of monocyte chemotactic protein-1 in the peritoneal fluid of patients with endometriosis. Fertil Steril 66,17-23.
4. Akoum A, Lemay A, Paradis I, Rheault N and Maheux R (1996b) Secretion of interleukin-6 by human endometriotic cells and regulation by proinflammatory cytokines and sex steroids. Hum Reprod 11,2269-2275.
5. Akoum A, Jolicoeur C, Kharfi A and Aube M (2001a) Decreased expression of the decoy interleukin-1 receptor type II in human endometriosis. Am J Pathol 158,481-489.
6. Akoum A, Lawson C, McColl S and Villeneuve M (2001b) Ectopic endometrial cells express high concentrations of interleukin (IL)-8 in vivo regardless of the menstrual cycle phase and respond to oestradiol by up-regulating IL-1-induced IL-8 expression in vitro. Mol Hum Reprod 7,859-866.
7. Akoum A, Lemay A and Maheux R (2002) Estradiol and interleukin-1beta exert a synergistic stimulatory effect on the expression of the chemokine regulated upon activation, normal T cell expressed, and secreted in endometriotic cells. J Clin Endocrinol Metab 87,5785-5792.
8. Barlow DH and Kennedy S (2005) Endometriosis: New genetic approaches and therapy. Anu Rev Med 56,345-356.
9. Bellehumeur C, Collette T, Maheux R, Mailloux J, Villeneuve M and Akoum A (2005) Increased soluble interleukin-1 receptor type II proteolysis in the endometrium of women with endometriosis. Hum Reprod 20,1177-1184.
10. Bergqvist A, Bruse C, Carlberg M and Carlstrom K (2001) Interleukin 1beta, interleukin-6, and tumor necrosis factor-alpha in endometriotic tissue and in endometrium. Fertil Steril 75,489-495.
11. Bigonnesse F, Labelle Y and Akoum A (2001) Triphasic expression of interleukin-1 receptor type I in human endometrium throughout the menstrual cycle of fertile women and women with unexplained infertility. Fertil Steril 75,79-87.
12. Boraschi D, Bossu P, Macchia G, Ruggiero P and Tagliabue A (1996) Structure-function relationship in the IL-1 family. Front Biosci 1,d270-d308.
13. Bossu P, Visconti U, Ruggiero P, Macchia G, Muda M, Bertini R, Bizzarri C, Colagrande A, Sabbatini V, Maurizi G et al. (1995) Transfected type II interleukin-1 receptor impairs responsiveness of human keratinocytes to interleukin-1. Am J Pathol 147,1852-1861.
14. Colotta F, Dower SK, Sims JE and Mantovani A (1994) The type II 'decoy' receptor: A novel regulatory pathway for interleukin 1. Immunol Today 15,562-566.
15. Colotta F, Orlando S, Fadlon EJ, Sozzani S, Matteucci C and Mantovani A (1995) Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells. J Exp Med 181,2181-2196.
16. Cui X, Rouhani FN, Hawari F and Levine SJ (2003) Shedding of the type II IL-1 decoy receptor requires a multifunctional aminopeptidase, aminopeptidase regulator of TNF receptor type 1 shedding. J Immunol 171,6814-6819.
17. Dinarello CA (2004) Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation. Curr Opin Pharmacol 4,378-385.
18. Fakih H, Baggett B, Holtz G, Tsang KY, Lee JC and Williamson HO (1987) Interleukin-1: A possible role in the infertility associated with endometriosis. Fertil Steril 47,213-217.
19. Giudice LC (2003) Genomics' role in understanding the pathogenesis of endometriosis. Semin Reprod Med 21,119-124.
20. Hill JA, Faris HM, Schiff I and Anderson DJ (1988) Characterization of leukocyte subpopulations in the peritoneal fluid of women with endometriosis. Fertil Steril 50,216-222.
21. Huang HF, Hong LH, Tan Y and Sheng JZ (2004) Matrix metalloproteinase 2 is associated with changes in steroid hormones in the sera and peritoneal fluid of patients with endometriosis. Fertil Steril 81,1235-1239.
22. Jolicoeur C, Boutouil M, Drouin R, Paradis I, Lemay A and Akoum A (1998) Increased expression of monocyte chemotactic protein-1 in the endometrium of women with endometriosis. Am J Pathol 152,125-133.
23. Jones RK, Bulmer JN and Searle RF (1998) Phenotypic and functional studies of leukocytes in human endometrium and endometriosis. Hum Reprod Update 4,702-709.
24. Kokorine I, Nisolle M, Donnez J, Eeckhout Y, Courtoy PJ and Marbaix E (1997) Expression of interstitial collagenase (matrix metalloproteinase-1) is related to the activity of human endometriotic lesions. Fertil Steril 68,246-251.
25. Lebovic DI, Bentzien F, Chao VA, Garrett EN, Meng YG and Taylor RN (2000) Induction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukin-1beta. Mol Hum Reprod 6,269-275.
26. Lebovic DI, Chao VA, Martini JF and Taylor RN (2001a) IL-1beta induction of RANTES (regulated upon activation, normal T cell expressed and secreted) chemokine gene expression in endometriotic stromal cells depends on a nuclear factor-kappaB site in the proximal promoter. J Clin Endocrinol Metab 86,4759-4764.
27. Lebovic DI, Mueller MD and Taylor RN (2001b) Immunobiology of endometriosis. Fertil Steril 75,1-10.
28. Mantovani A, Muzio M, Ghezzi P, Colotta F and Introna M (1996) Negative regulators of the interleukin-1 system: Receptor antagonists and a decoy receptor. Int J Clin Lab Res 26,7-14.
29. Mori H, Sawairi M, Nakagawa M, Ithoh N, Wada K and Tamaya T (1992) Expression of interleukin-1 (IL-1) beta messenger ribonucleic acid (mRNA) and IL-1 receptor antagonist mRNA in peritoneal macrophages from patients with eadometriosis. Fertil Steril 57,535-542.
30. Nisolle M, Casana-Roux F and Donnez J (1997) Immunohistochemical analysis of proliferative activity and steroid receptor expression in peritoneal and ovarian endometriosis. Fertil Steril 68,912-919.
31. Noyes RW, Hertig AT and Rock J (1975) Dating the endometrial biopsy. Am J Obstet Gynecol 122,262-263.
32. Revised American Society (1997) Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 67,817-821.
33. Orlando S, Sironi M, Bianchi G, Drummond AH, Boraschi D, Yabes D and Mantovani A (1997) Role of metalloproteases in the release of the IL-1 type II decoy receptor. J Biol Chem 272,31764-31769.
34. Ota H, Igarashi S, Hayakawa M, Matsui T, Tanaka H and Tanaka T (1996) Effect of danazol on the immunocompetent cells in the eutopic endometrium in patients with endometriosis: A multicenter cooperative study. Fertil Steril 65,545-551.
35. Sampson J (1927) Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 14,422-469.
36. Sharpe-Timms KL (2005) Defining endometrial cells: The need for improved identification at ectopic sites and characterization in eutopic sites for developing novel methods of management for endometriosis. Fertil Steril 84,35-39.
37. Sillem M, Prifti S, Monga B, Arslic T and Runnebaum B (1999) Integrin-mediated adhesion of uterine endometrial cells from endometriosis patients to extracellular matrix proteins is enhanced by tumor necrosis factor alpha (TNF alpha) and interleukin-1 (IL-1). Eur J Obstet Gynecol Reprod Biol 87,123-127.
38. Simon C, Piquette GN, Frances A, el-Danasouri I, Irwin JC and Polan ML (1994) The effect of interleukin-1 beta (IL-1 beta) on the regulation of IL-1 receptor type I messenger ribonucleic acid and protein levels in cultured human endometrial stromal and glandular cells. J Clin Endocrinol Metab 78,675-682.
39. Subramaniam S, Stansberg C and Cunningham C (2004) The interleukin 1 receptor family. Dev Comp Immunol 28,415-428.
40. Symons JA, Young PR and Duff GW (1995) Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist. Proc Natl Acad Sci USA 92,1714-1718.
41. Szamatowicz J, Laudanski P and Tomaszewska I (2002) Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1: a possible role in the pathogenesis of endometriosis. Hum Reprod 17,284-288.
42. Taketani Y, Kuo TM and Mizuno M (1992) Comparison of cytokine levels and embryo toxicity in peritoneal fluid in infertile women with untreated or treated endometriosis. Am J Obstet Gynecol 167,265-270.
43. Taylor RN and Mueller MD (2004) Anti-angiogenic treatment of endometriosis: Biochemical aspects. Gynecol Obstet Invest 57,54-56.
44. Ulukus M and Arici A (2005) Immunology of endometriosis. Minerva Ginecol 57,237-248.
45. Wiegerinck MA, Van Dop PA and Brosens IA (1993) The staging of peritoneal endometriosis by the type of active lesion in addition to the revised American Fertility Society classification. Fertil Steril 60,461-464.
46. Witz CA (2002) Pathogenesis of endometriosis. Gynecol Obstet Invest 53 (Suppl 1),52-62.
47. Zeller JM, Henig I, Radwanska E and Dmowski WP (1997) Enhancement of human monocyte and peritoneal macrophage chemiluminescence activities in women with endometriosis. Am J Reprod Immunol Microbiol 13,78-82.